Skip to main content
KLTO
NASDAQ Life Sciences

Klotho Neurosciences Acquires Greenland Mines Corp. in Transformational Reverse Merger, Pivoting to Critical Minerals

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
10
Price
$0.426
Mkt Cap
$30.341M
52W Low
$0.114
52W High
$3.91
52W Position info
275% above low
Off High info
89% below high
Rel. Volume info
22× avg
Market data snapshot near publication time

KLTO has more than doubled off its 52-week low of $0.114 on elevated volume (22× avg).

Summary

Klotho Neurosciences is undergoing a complete business transformation, acquiring Greenland Mines Corp. in a reverse merger to gain control of a $68 billion critical mineral deposit, pivoting from biotech to a dual-division company with significant dilution for existing shareholders.


Key Events · M&A and Partnerships · KLTO

  • Acquisition of Greenland Mines Corp.

    Klotho Neurosciences has acquired Greenland Mines Corp., a privately held company controlling an 80% interest in the Skaergaard Project in Southeast Greenland.

  • Strategic Business Pivot

    The acquisition marks a fundamental shift, transforming Klotho from solely a cell and gene therapy company into a dual-division entity, now including Natural Resources focused on critical mineral exploration.

  • Massive Mineral Asset Acquired

    The Skaergaard Project is described as one of the world's largest undeveloped palladium, gold, and platinum deposits, with an estimated gross undiscounted in-situ resource value of approximately $68 billion.

  • Reverse Merger & Significant Dilution

    The transaction is structured as a reverse merger, with consideration in convertible preferred stock. Post-conversion, Greenland Mines Corp. shareholders are expected to own approximately 93% of the fully diluted shares, indicating substantial dilution for existing Klotho shareholders.


Analysis · KLTO · Life Sciences

This 8-K officially discloses Klotho Neurosciences' acquisition of Greenland Mines Corp. in a reverse merger, fundamentally altering the company's business model from cell and gene therapy to a dual focus including natural resources. The acquisition grants control over the Skaergaard Project, a significant palladium, gold, and platinum deposit with an estimated $68 billion in-situ resource value. This strategic pivot, coupled with the issuance of convertible preferred stock that will result in Greenland Mines Corp. shareholders owning approximately 93% of the fully diluted shares, represents a complete transformation of the company's asset base, ownership, and future direction. Investors should be aware of the significant dilution and the shift into a completely different industry. The company plans to rebrand and change its stock ticker, signaling a new era for the entity.

At the time of this filing, KLTO was trading at $0.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.3M. The 52-week trading range was $0.11 to $3.91. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KLTO - Latest Insights

KLTO
Mar 12, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.5339
Real-time Price: $0.5339 info
Change: $0 (0%) info
Market Cap: $38.548M info
KLTO
Mar 10, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.5144
Real-time Price: $0.5339 info
Change: +$0.0195 (+4%) info
Market Cap: $38.548M info
KLTO
Mar 04, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
10
Price at Filing: $0.530
Real-time Price: $0.5339 info
Change: +$0.0039 (+0.74%) info
Market Cap: $38.548M info
KLTO
Mar 02, 2026, 5:03 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5797
Real-time Price: $0.5339 info
Change: -$0.0458 (-8%) info
Market Cap: $38.548M info
KLTO
Feb 24, 2026, 6:12 AM EST
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.380
Real-time Price: $0.5339 info
Change: +$0.1539 (+41%) info
Market Cap: $38.548M info